Effects of HIIT and Dual-Task Training in Children With ADHD
NCT07863362, Not applicable, Completed, Hasan Kalyoncu University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of HIIT and Dual-Task Training in Children With ADHD | ClinicalTrials.gov |
| NCT number | NCT07863362 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 30 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Hasan Kalyoncu University | ClinicalTrials.gov |
| Conditions | Attention-Deficit/Hyperactivity Disorder (ADHD), Physiotherapy | ClinicalTrials.gov |
| Interventions | High-Intensity Interval Training With Dual-Task Training | ClinicalTrials.gov |
| First posted | 2026-10-07 | ClinicalTrials.gov |
| Last updated | 2026-10-07 | ClinicalTrials.gov |
Registered outcomes 5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Attention Performance Assessed by the D2 Test of Attention | Baseline, 8 weeks, and 3-month follow-up | Attention performance was assessed using the D2 Test of Attention, which evaluates selective and sustained attention and processing performance. Changes in D2 test performance were evaluated across the study time points. | ClinicalTrials.gov |
| Primary | Strobe Test | Baseline, 8 weeks, and 3-month follow-up | The Stroop Test is a psychological test widely used to assess attention, cognitive control and executive functions. First developed in 1935 by John Ridley Stroop, its validity and reliability in Turkish were established in 1999 by Karakaş et al.; it is a test model used specifically to assess attention processes, selective attention, cognitive flexibility and response inhibition. The Stroop Test measures an individual's ability to suppress an automatic response (for example, reading the written word) in order to perform a more difficult task (naming the colour of the word). | ClinicalTrials.gov |
| Primary | Bruininks-Oseretsky Test of Motor Proficiency | Baseline, 8 weeks, and 3-month follow-up | This test was developed by Robert H. Bruininks to comprehensively assess the motor development levels of individuals aged between 4 and 21. The adaptation to Turkey and the validity and reliability studies were carried out by Hürmeriç Altunsöz, Kahraman and Gürpınar, and the test was found to have high internal consistency (Cronbach's α \> 0.80). The BOT-2 comprises eight subtests: fine motor sensitivity, fine motor integration, manual dexterity, body coordination, balance, strength, agility and upper body coordination. Each subtest includes various tasks, and scoring is based on task performance. The raw scores obtained are expressed as standardised scores and percentile ranks. Low scores indicate deficits in motor coordination or developmental delays, whilst high scores indicate adequate cognitive-motor performance. . | ClinicalTrials.gov |
| Secondary | Social Adaptation and Skills Scale | Baseline, 8 weeks, and 3-month follow-up | This scale was developed to assess children's behaviours such as adaptation to their social environment, establishing and maintaining social relationships, aggression and altruism. Behaviours relating to social skills are scored using Likert-type statements; the scale comprises subdimensions such as cooperation, communication and self-control. The scores obtained from each subdimension contribute to the total social adjustment score. High scores indicate that the child has adequate social skills, whilst low scores suggest that there may be problems with social adjustment. | ClinicalTrials.gov |
| Secondary | Quality of Life Scale for Children (PedsQOL) | Baseline, 8 weeks, and 3-month follow-up | The scale consists of both child and parent assessment forms and assesses four sub-dimensions: physical functioning, social functioning, school life and emotional well-being. Comprising 5-point Likert-type questions, the scale measures the child's quality of life based on their experiences over the past week. Scores for each sub-scale are rated on a scale of 0-100. Higher scores indicate a better quality of life, whilst lower scores suggest difficulties in the relevant area. The parent and child forms are assessed separately, allowing results to be obtained from different perspectives. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 6
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Cancellation Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)